Page last updated: 2024-11-02

pargyline and Glaucoma

pargyline has been researched along with Glaucoma in 2 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tatton, WG1
Chalmers-Redman, RM1
Sud, A1
Podos, SM1
Mittag, TW1
Mehra, KS1
Roy, PN1
Singh, R1

Reviews

1 review available for pargyline and Glaucoma

ArticleYear
Maintaining mitochondrial membrane impermeability. an opportunity for new therapy in glaucoma?
    Survey of ophthalmology, 2001, Volume: 45 Suppl 3

    Topics: Animals; Apoptosis; bcl-X Protein; Brimonidine Tartrate; Cell Membrane Permeability; Glaucoma; Human

2001

Trials

1 trial available for pargyline and Glaucoma

ArticleYear
Pargyline drops in glaucoma.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1974, Volume: 92, Issue:6

    Topics: Adult; Drug Evaluation; Glaucoma; Humans; Ophthalmic Solutions; Pargyline; Placebos; Tonometry, Ocul

1974